Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AM (2021) Medical imaging and nuclear medicine: a Lancet Oncology Commission. Lancet Oncol 22(4):e136–e172. https://doi.org/10.1016/s1470-2045(20)30751-8

Article  PubMed  PubMed Central  Google Scholar 

Woodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, Vaughan AS (2024) Trends in cardiovascular disease mortality rates and excess deaths, 2010–2022. Am J Prev Med 66(4):582–589. https://doi.org/10.1016/j.amepre.2023.11.009

Article  PubMed  Google Scholar 

Permuth-Wey J, Egan KM (2009) Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 8(2):109–117. https://doi.org/10.1007/s10689-008-9214-8

Article  PubMed  Google Scholar 

Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Maire F, Hammel P, Ruszniewski P, Lévy P (2008) Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 103(1):111–119. https://doi.org/10.1111/j.1572-0241.2007.01597.x

Article  PubMed  Google Scholar 

DiMagno EP, Reber HA, Tempero MA (1999) AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117(6):1464–1484. https://doi.org/10.1016/s0016-5085(99)70298-2

Article  CAS  PubMed  Google Scholar 

Mack TM, Yu MC, Hanisch R, Henderson BE (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76(1):49–60

CAS  PubMed  Google Scholar 

Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, Yagyu K, Motohashi Y, Tamakoshi A (2005) Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15(Suppl 2):S157-167. https://doi.org/10.2188/jea.15.s157

Article  PubMed  PubMed Central  Google Scholar 

Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer (Oxford, England: 1990) 47(13):1928–1937. https://doi.org/10.1016/j.ejca.2011.03.003

Article  Google Scholar 

Miyashita Y, Hitsumoto T, Fukuda H, Kim J, Ito S, Kimoto N, Asakura K, Yata Y, Yabumoto M, Washio T, Kitakaze M (2024) Metabolic syndrome is linked to the incidence of pancreatic cancer. EClinicalMedicine 67:102353. https://doi.org/10.1016/j.eclinm.2023.102353

Article  PubMed  Google Scholar 

Paku M, Uemura M, Kitakaze M, Miyoshi N, Takahashi H, Mizushima T, Doki Y, Eguchi H (2023) Clinical significance of preoperative and postoperative serum CEA and carbohydrate antigen 19-9 levels in patients undergoing curative resection of locally recurrent rectal cancer. Dis Colon Rectum 66(3):392–400. https://doi.org/10.1097/DCR.0000000000002655

Article  PubMed  Google Scholar 

Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA (2022) Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev 38(3):e3502. https://doi.org/10.1002/dmrr.3502

Article  CAS  PubMed  Google Scholar 

Watanabe J, Kotani K (2020) Metabolic syndrome for cardiovascular disease morbidity and mortality among general Japanese people: a mini review. Vasc Health Risk Manag 16:149–155. https://doi.org/10.2147/vhrm.S245829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505–1522. https://doi.org/10.2353/ajpath.2006.051090

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35(11):2402–2411

Article  PubMed  PubMed Central  Google Scholar 

Yamagishi K, Iso H (2017) The criteria for metabolic syndrome and the national health screening and education system in Japan. Epidemiol Health 39:e2017003. https://doi.org/10.4178/epih.e2017003

Article  PubMed  PubMed Central  Google Scholar 

(2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486–2497 https://doi.org/10.1001/jama.285.19.2486

Spector TD, Thompson SG (1991) The potential and limitations of meta-analysis. J Epidemiol Community Health 45(2):89

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anazawa T, Miyata H, Gotoh M (2015) Cancer registries in Japan: National Clinical Database and site-specific cancer registries. Int J Clin Oncol 20:5–10

Article  CAS  PubMed  Google Scholar 

Shen B, Li Y, Sheng C-S, Liu L, Hou T, Xia N, Sun S, Miao Y, Pang Y, Gu K (2023) Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study. Lancet Reg Health Western Pac 30:100596

Article  Google Scholar 

Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA (2011) Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 54(2):463–471

Article  PubMed  Google Scholar 

Asrih M, Jornayvaz FR (2015) Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link? Mol Cell Endocrinol 418:55–65

Article  CAS  PubMed  Google Scholar 

Orabi D, Berger NA, Brown JM (2021) Abnormal metabolism in the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma: mechanistic insights to chemoprevention. Cancers 13(14):3473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24(3):349–358

Article  PubMed  Google Scholar 

Dhar D, Baglieri J, Kisseleva T, Brenner DA (2020) Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 245(2):96–108. https://doi.org/10.1177/1535370219898141

Article  CAS  PubMed  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84. https://doi.org/10.1002/hep.28431

Article  PubMed  Google Scholar 

Nagel G, Stocks T, Späth D, Hjartåker A, Lindkvist B, Hallmans G, Jonsson H, Bjørge T, Manjer J, Häggström C (2012) Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol 91:1519–1531

Article  CAS  PubMed  Google Scholar 

Ibrahim YH, Yee D (2004) Insulin-like growth factor-I and cancer risk. Growth Hormone IGF Res 14(4):261–269. https://doi.org/10.1016/j.ghir.2004.01.005

Article  CAS  Google Scholar 

Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56(4):549–580. https://doi.org/10.1124/pr.56.4.3

Article  CAS  PubMed  Google Scholar 

Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97(1):72–81

Article  CAS  PubMed  Google Scholar